Currently, GLP-1RAsincluding liraglutide, exenatide, dulaglutide, semaglutide, and albiglutidehave gained substantial attention in cardiovascular disease research, beyond their established role in glycemic management for patients with obesity and T2DM
Author contributions HE-S: conceptualization, ultrasonographic examination, biochemical analysis, data curation, and manuscript writing
The brightening effect is genuine, not just marketing
Posterior capsule opacification and anterior capsule opacification
PubMed PMID 9849822 original pharmacology report describing Ipamorelin as a selective growth-hormone secretagogue in the studied experimental systems
GLP-1 S is semaglutide, a long-acting and selective GLP-1 receptor agonist